Picoquant invests in Fluobrick Solutions to simplify access to single molecule research
Cristiana Gigina
PicoQuant GmbH Sep 25 2025 PicoQuant GmbH announces its investment in FluoBrick Solutions GmbH, a newly founded Berlin-based start-up focused on giving life science researchers in academia and pharma diagnostics access to the power of single molecule techniques. Rainer Erdmann from PicoQuant (middle), Dr. Gabriel Moya (right) and Prof. Dr. Thorben Cordes (left) from FluoBrick Solutions seal their partnership to jointly foster innovation in single-molecule research. Image Credit: PicoQuant GmbH
astăzi